Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
1.
Ann Cardiol Angeiol (Paris) ; 64(3): 199-204, 2015 Jun.
Article de Français | MEDLINE | ID: mdl-26044304

RÉSUMÉ

INTRODUCTION: Cardiovascular diseases remain the first cause of death in women. To improve women's health cardiologists and gynaecologists should work together on women's specific cardiovascular risk factor. METHOD: Our study evaluated a care pathway named "heart, arteries and women". One hundred and ninety-one women were included for vascular (n=55) or hypertensive (n=136) explorations from January the first to December the 31st of 2013. We studied their clinical presentation and medical management. RESULTS: All women were at high cardiovascular risk (38% of them at very high risk). The average age was 52 years old. A woman on three had experienced high blood pressure or diabetes during pregnancy. One on two was postmenopausal woman. We stopped twelve estrogen-progesterone contraceptions; 60% didn't have gynaecological follow-up; 146 had high blood pressures (73% at night, 50% had no dipping blood pressure profile and 15 were newly diagnosed for hypertension). Sleep apnoea syndrome was suspected in half women. Medical therapies were optimized especially for women with atheroma in which 30 to 46% were properly treated (P=0.0005). Only 18% of the gynecologists received conclusive reports. CONCLUSION: At one year, our care pathway "heart, arteries and women" allowed to optimize medical therapy and clinical management. Everyone should be aware of this program.


Sujet(s)
Maladies cardiovasculaires/diagnostic , Maladies cardiovasculaires/thérapie , Adulte , Artères , Programme clinique , Femelle , Humains , Hypertension artérielle/diagnostic , Hypertension artérielle/thérapie , Adulte d'âge moyen , Études rétrospectives , Facteurs de risque , Facteurs temps , Santé des femmes
2.
J Mal Vasc ; 40(1): 10-7, 2015 Feb.
Article de Français | MEDLINE | ID: mdl-25631643

RÉSUMÉ

AIM: Masked hypertension (MH) is defined by a normal office blood pressure (BP) and a high ambulatory BP. MH is characterized by high prevalence and poor cardiovascular prognosis. The aim of this study was to evaluate the usefulness of routine MH screening, using 24-h blood pressure monitoring (BPM), among patients with peripheral arterial disease (PAD). METHODS: Between 2011 and 2013, 54 patients with PAD were included in the Hypertension and Vascular Medicine Unit of the Lille Hospital. They had normal office BP (< 140/90mmHg). A 24 h-BPM device was set on each patient. MH diagnosis was established if the BP average over 24 hours was ≥ 130/80 mmHg and/or the daytime average ≥ 135/85 mmHg and/or the nighttime average ≥ 120/70 mmHg. RESULTS: MH prevalence was about 42.6% (23 patients). It was significantly more frequent in diabetic patients (odds ratio: 3.8 [1.1-12.8]), in patients with known hypertension (odds ratio: 5 [1.5-16.9]) or with high normal office BP (<140/90 mmHg but ≥ 130/85 mmHg) (odds ratio: 5.6 [1.7-18.2]). By multivariate analysis, only known hypertension and high normal office BP were associated with masked hypertension. CONCLUSION: The high prevalence of MH in patients with PAD shows us the importance of a careful screening of MH in this population, especially in diabetic patients, in patients with known hypertension or with a high normal office BP.


Sujet(s)
Hypertension masquée/diagnostic , Maladie artérielle périphérique/complications , Maladie artérielle périphérique/physiopathologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Pression sanguine , Surveillance ambulatoire de la pression artérielle , Complications du diabète/épidémiologie , Diabète/physiopathologie , Femelle , France/épidémiologie , Humains , Mâle , Hypertension masquée/épidémiologie , Dépistage de masse , Adulte d'âge moyen , Odds ratio , Projets pilotes
3.
Ann Cardiol Angeiol (Paris) ; 63(3): 192-6, 2014 Jun.
Article de Français | MEDLINE | ID: mdl-24972987

RÉSUMÉ

Cardiovascular (CV) diseases are the primary cause of death of women. Since they kill 10 times more than breast cancer, preventive measures should be implemented. According to U.S. recommendations, a woman is either at "CV risk" or at "optimal health status" if she has no risk factors and a perfectly healthy lifestyle. Some risk factors are more deleterious to women (smoking, diabetes, stress, depression, atrial fibrillation); or specific to women (preeclampsia, gestational diabetes, contraception, menopause, headaches). The lifestyle plays a key role for them. The blood pressure measurement is the most frequent opportunity to detect women at risk. CV tests should be performed to all symptomatic women and for those over the age of 45 who want to start practicing sport. The cardiologist can play a key role to improve women's CV health by integrating their hormonal risks. Women themselves can also make a powerful contribution to prevention by adopting a healthy lifestyle. From those recommendations concerning women's CV health, there is a great opportunity to initiate a health path for women at high cardiovascular risk. The objectives of the specific path "heart, arteries and women" of University hospital of Lille will be to improve professional practice, awareness of women, educate public authorities and within a few years reduce the epidemic of CVD of French women.


Sujet(s)
Artères , Maladies cardiovasculaires/prévention et contrôle , Ventricules cardiaques , Mode de vie , Santé des femmes , Adulte , Artères/anatomopathologie , Fibrillation auriculaire/complications , Maladies cardiovasculaires/diagnostic , Maladies cardiovasculaires/épidémiologie , Maladies cardiovasculaires/étiologie , Contraceptifs oraux hormonaux/effets indésirables , Dépression/complications , Complications du diabète/prévention et contrôle , Diabète gestationnel/prévention et contrôle , Femelle , France/épidémiologie , Connaissances, attitudes et pratiques en santé , Ventricules cardiaques/anatomopathologie , Humains , Ménopause , Pré-éclampsie/prévention et contrôle , Grossesse , Appréciation des risques , Facteurs de risque , Fumer/effets indésirables , Stress psychologique/complications
4.
J Mal Vasc ; 39(1): 4-13, 2014 Feb.
Article de Français | MEDLINE | ID: mdl-24119421

RÉSUMÉ

BACKGROUND: Therapeutic inertia (TI) is a recent concept still unknown by many physicians. In chronic diseases such as hypertension, it is defined as the tendency of physicians not to increase or change antihypertensive medications when the target blood pressure is not reached. Acting on TI could improve blood pressure control in France. METHOD: This was a single-center prospective pilot study conducted by hypertension specialist physicians at the University Cardio-Vascular Center in Lille (France). It was conducted between March and June 2011. Data was collected from 161 hypertensive patients (mean age: 61.64±11.18 years; 98 (60.9%) male; 75 secondary prevention patients). Each physician completed a questionnaire on therapeutic inertia. TI was defined as a consultation in which treatment change was indicated (systolic blood pressure [BP]≥140 and/or diastolic BP≥90mmHg in all patients), but did not occur, with absence of an adapted justification of this choice. We considered as an adapted justification: a white coat effect demonstrated by ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring; scheduled reassessment of the BP by ABPM; recent change in antihypertensive treatment (less than 4 weeks); hospitalization needed for complete evaluation of secondary causes of hypertension and a more detailed assessment of potential target organ damage in patients with grade 1 or 2 hypertension. Our study aimed to evaluate rates of TI, to identify factors associated with TI, and to test the TI questionnaire. RESULTS: Therapeutic inertia as defined in this study occurred in 11 consultations (8.3%) of the 133 hypertensive patients having uncontrolled BP above or equal to 140 and/or 90mmHg. Significant factors associated with TI were older age (Z=2.35, P<0.05) and sleep apnea syndrome (χ(2)=8.33, P<0.05). The absence of ambulatory blood pressure monitoring before the consultation (χ(2)=4.28, 0.1>P>0.05) and the number of consultations (Z=1.92, 0.1>P>0.05) exhibited a significant trend to be associated with TI. CONCLUSIONS: Although the rate of TI was low in our study conducted in a specialized center, a well-accepted definition of therapeutic inertia would be useful for further study. The feasibility of using the questionnaire tested with this study shows that this measurement tool could help physicians become more aware of TI, both in the hospital and primary care setting. Further multicenter studies are needed for validation.


Sujet(s)
Antihypertenseurs/usage thérapeutique , Attitude du personnel soignant , Cardiologie , Hypertension artérielle/traitement médicamenteux , Types de pratiques des médecins , Enquêtes et questionnaires , Sujet âgé , Mesure de la pression artérielle , Résistance aux substances , Substitution de médicament/psychologie , Femelle , Humains , Mâle , Adulte d'âge moyen , Relations médecin-patient , Projets pilotes , Guides de bonnes pratiques cliniques comme sujet , Études prospectives
5.
Ann Cardiol Angeiol (Paris) ; 62(3): 204-9, 2013 Jun.
Article de Français | MEDLINE | ID: mdl-23759734

RÉSUMÉ

UNLABELLED: HTA Vasc offers an approved educational program for hypertensive patients at high cardiovascular risk (CVR). METHOD: A telephone survey (December 2011-July 2012) evaluated the benefits of different workshops "my treatment", "my blood pressure" and "my nutrition", more than 6 months after the end of the program. The follow-up data (TS) were compared to inclusion data (T0) and to final data (TF) in 73 hypertensive patients. RESULTS: The follow-up period was 6 to 31 months. The number of hypertensive controlled patients [blood pressure (BP)<140/90 mmHg] increased from 55.4% to 75.4% (P=0.0158) in TF, which remained over time. The practice of physical activity increased from 47.9% (T0) to 79.5% (TS) (P=0.001). The follow-up period of 18 months or more was associated with a tendency to weight gain (P=0.0059) and with a decline in physical activity [89.7% (<18 months) to 67.5% (≥ 18 months) (P=0.0198)]. The practice of self-measurement BP increased from 41.1% (T0) to 71.2% (TS) (P<0.0001); knowledge of the "rule of three" increased from 6.8% (T0) to 74% (TS) (P<0.0001). CONCLUSION: An educational support contributes to a better long-term BP control. The motivation for lifestyle rules decreases with time. The implementation of a structured motivational follow-up could maintain the lifestyle motivation at these CVR patients.


Sujet(s)
Antihypertenseurs/usage thérapeutique , Surveillance ambulatoire de la pression artérielle , Pression sanguine/effets des médicaments et des substances chimiques , Éducation pour la santé/organisation et administration , Hypertension artérielle/traitement médicamenteux , Activité motrice , Téléphone , Perte de poids , Sujet âgé , Surveillance ambulatoire de la pression artérielle/statistiques et données numériques , Femelle , Études de suivi , France , Éducation pour la santé/normes , Enquêtes de santé , Humains , Hypertension artérielle/thérapie , Mâle , Adulte d'âge moyen , Évaluation de programme , Facteurs de risque , Enquêtes et questionnaires , Facteurs temps
6.
J Mal Vasc ; 37(1): 26-9, 2012 Feb.
Article de Français | MEDLINE | ID: mdl-22285840

RÉSUMÉ

This clinical case illustrates the management difficulties encountered during gestational hypertension and its impact on maternal and foetal outcome. Typically, preeclampsia occurs at the end of the second trimester. If blood pressure remains high early during pregnancy, a secondary cause of hypertension such as renal artery fibromuscular dysplasia should be explored. A renal vascular etiology can be safely ruled out with a duplex ultrasound. In this particular case of renal vascular hypertension in a patient with a single kidney, angioplasty appeared to be the sole solution and was efficient.


Sujet(s)
Angioplastie , Dysplasie fibromusculaire/complications , Dysplasie fibromusculaire/chirurgie , Hypertension artérielle gravidique/étiologie , Complications cardiovasculaires de la grossesse/chirurgie , Artère rénale , Adulte , Césarienne , Femelle , Dysplasie fibromusculaire/diagnostic , Humains , Hypertension rénovasculaire/étiologie , Grossesse , Complications cardiovasculaires de la grossesse/diagnostic , Premier trimestre de grossesse
7.
Eur J Vasc Endovasc Surg ; 42(6): 797-802, 2011 Dec.
Article de Anglais | MEDLINE | ID: mdl-21962588

RÉSUMÉ

AIM: To evaluate contrast-enhanced ultrasound (CEUS) as an effective alternative to CT-angiography (CTA) for endoleak detection and aneurismal sac diameter measurement in the follow-up after endovascular abdominal aortic aneurysm repair (EVAR). METHODS: From January 2006 to December 2010, 395 patients underwent EVAR follow-up with both CTA and CEUS. The diameter of the aneurismal sac and the presence of endoleaks were evaluated in all the 395 paired examinations. RESULTS: Bland-Altman plots showed a good agreement in aneurismal sac diameter evaluation between the two imaging modalities. The mean diameter was 54.93 mm (standard deviation (SD) ±12.57) with CEUS and 56.01 mm (SD ± 13.23) with CTA. The mean difference in aneurismal sac diameter was -1.08 mm ± 3.3543 (95% confidence interval (CI), -0.75 to -1.41), in favour of CTA. The number of observed agreement in endoleak detection was 359/395 (90.89%). The two modalities detected the same type I and type III endoleaks. McNemar's χ(2) test confirmed that CTA and CEUS are equivalent in endoleak detection. CONCLUSIONS: CEUS demonstrated to be as accurate as CTA in endoleak detection and abdominal aortic aneurysm diameter measurements during EVAR follow-up, without carrying the risks of radiation exposure or nephrotoxicity. Even if it cannot be proposed as the sole imaging modality during follow-up, our analysis suggests that it should have a major role.


Sujet(s)
Angioplastie , Anévrysme de l'aorte abdominale/diagnostic , Anévrysme de l'aorte abdominale/thérapie , Aortographie , Implantation de prothèses vasculaires , Produits de contraste , Endofuite/diagnostic , Iohexol , Iopamidol/analogues et dérivés , Phospholipides , Hexafluorure de soufre , Tomodensitométrie , Échographie-doppler couleur , Écho-Doppler pulsé , Études de suivi , Humains , Conception de prothèse , Sensibilité et spécificité
8.
J Mal Vasc ; 35(3): 175-8, 2010 Jun.
Article de Français | MEDLINE | ID: mdl-20079987

RÉSUMÉ

A 24-year-old African who had been living in France for few years first consulted at our institution for severe systemic hypertension. He had no prior medical or surgical history. The patient was strictly asymptomatic. Except for systemic hypertension at both arms, the basic physical examination was normal with no cardiac murmur and no pulse deficit. A 24-hour ambulatory blood pressure monitoring performed before the consultation confirmed the presence of systemic hypertension with a mean blood pressure at 155/90mmHg during the day and also during the night under anti-hypertensive treatment. Ankle-brachial index measurement was low at 0.8 at both legs. Subsequently, a trans-thoracic echocardiography (TTE) and an aortic CT-scanner were performed. The TTE did not find any abnormalities including no aortic dilatation or no ventricular hypertrophy. The CT-scanner revealed a partial aortic coarctation. The patient underwent aortic surgery and recovered in few days with quite normal blood pressure under medical treatment. In conclusion, systematic ankle-brachial index is useful and recommended in every patient at first visit for systemic hypertension. Its safety and simplicity make it an essential tool in the management of systemic hypertension especially in populations with no systematic screening of aortic coarctation in childhood. It was in the present case very useful for the final diagnosis and treatment. In addition, it is an efficient tool to screen patients with asymptomatic peripheral artery disease and it can help for stratification of cardiovascular risk.


Sujet(s)
Index de pression systolique cheville-bras , Coarctation aortique/diagnostic , Coarctation aortique/complications , Humains , Hypertension artérielle/complications , Hypertension artérielle/diagnostic , Mâle , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...